Spots Global Cancer Trial Database for lymphoblastic leukemia, acute
Every month we try and update this database with for lymphoblastic leukemia, acute cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED) | NCT00798213 | Leukemia, Myelo... Lymphoblastic L... | SCH 727965 Gemtuzumab ozog... | 18 Years - | Merck Sharp & Dohme LLC | |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) | NCT01186328 | Lymphoblastic L... Lymphoblastic L... Leukemia, Lymph... Leukemia, Lymph... | EZN-3042 Cytarabine Doxorubicin Prednisone Vincristine PEG-asparaginas... Methotrexate Hydrocortisone | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia | NCT00114348 | Lymphoblastic L... Lymphoma, Non-H... | R-Blocks Protocol II-Ida | - 18 Years | Charite University, Berlin, Germany | |
| Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALL | NCT02888977 | Lymphoblastic L... | 18 Years - 55 Years | Versailles Hospital | ||
| Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | NCT00137111 | Lymphoblastic L... | Prednisone, Dex... Doxorubicin, L-... Methotrexate, C... Mercaptopurine,... chemotherapy, i... steroid therapy... | 12 Months - 18 Years | St. Jude Children's Research Hospital | |
| Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL) | NCT00131053 | Lymphoblastic L... | Methotrexate Prednisolone Dexamethasone Vincristine Pirarubicin Cyclophosphamid... L-asparaginase Cytarabine Hydrocortisone Mercaptopurine | 15 Years - 24 Years | Japan Adult Leukemia Study Group | |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors | NCT01100658 | ALL, Childhood Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphocytic Leu... Lymphocytic Leu... Lymphocytic Leu... Brain Tumors Cancer of the B... Cancer of Brain Malignant Prima... Brain Neoplasms... | Methylphenidate Placebo | 8 Years - 17 Years | University of Minnesota | |
| ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia | NCT00114348 | Lymphoblastic L... Lymphoma, Non-H... | R-Blocks Protocol II-Ida | - 18 Years | Charite University, Berlin, Germany | |
| Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia | NCT00995137 | Lymphoblastic L... | NK Cell Infusio... | - 18 Years | St. Jude Children's Research Hospital | |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors | NCT01100658 | ALL, Childhood Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphocytic Leu... Lymphocytic Leu... Lymphocytic Leu... Brain Tumors Cancer of the B... Cancer of Brain Malignant Prima... Brain Neoplasms... | Methylphenidate Placebo | 8 Years - 17 Years | University of Minnesota | |
| SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED) | NCT00798213 | Leukemia, Myelo... Lymphoblastic L... | SCH 727965 Gemtuzumab ozog... | 18 Years - | Merck Sharp & Dohme LLC | |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) | NCT01186328 | Lymphoblastic L... Lymphoblastic L... Leukemia, Lymph... Leukemia, Lymph... | EZN-3042 Cytarabine Doxorubicin Prednisone Vincristine PEG-asparaginas... Methotrexate Hydrocortisone | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Treatment of Adult Ph+ LAL With BMS-354825 | NCT00391989 | Lymphoblastic L... | Dasatinib | 18 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Treatment of Adult Ph+ LAL With BMS-354825 | NCT00391989 | Lymphoblastic L... | Dasatinib | 18 Years - | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) | NCT00131027 | Lymphoblastic L... | Cyclophosphamid... Daunorubicin Vincristine Prednisolone L-asparaginase Cytarabine Etoposide Dexamethasone Methotrexate Mercaptopurine Doxorubicin Methotrexate | 25 Years - 64 Years | Japan Adult Leukemia Study Group | |
| Therapy for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia | NCT00137111 | Lymphoblastic L... | Prednisone, Dex... Doxorubicin, L-... Methotrexate, C... Mercaptopurine,... chemotherapy, i... steroid therapy... | 12 Months - 18 Years | St. Jude Children's Research Hospital | |
| Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL | NCT02879643 | ALL, Childhood Lymphoblastic L... Lymphoblastic L... | Marqibo | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium | |
| Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy for Children, Adolescents, and Young Adults With Relapsed ALL | NCT02879643 | ALL, Childhood Lymphoblastic L... Lymphoblastic L... | Marqibo | 1 Year - 21 Years | Therapeutic Advances in Childhood Leukemia Consortium |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
